| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Strategy Officer
1 company
Aurora Daljit Singh is a See Remarks at NMRA. Recent filings cover 0 purchases and 14 sales.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | NMRA Neumora Therapeutics, Inc. | See Remarks | Sale+OE | 176,060 | $1.53 | $269,966.97 | - | - | - | |
| Aug 19, 2026 | NMRA Neumora Therapeutics, Inc. | See Remarks | Sale+OE | 277,773 | $1.55 | $431,674.11 | - | - | - | |
| Feb 17, 2026 | NMRA Neumora Therapeutics, Inc. | See Remarks | Sell | 6,165 | $3.56 | $21,916.58 | -6.9% | -50.0% | - | |
| Nov 11, 2025 | NMRA Neumora Therapeutics, Inc. | See Remarks | Sell10b5-1 | 114,703 | $2.68 | $307,025.52 | -100% | -13.1% | - | |
| Feb 18, 2025 | NMRA Neumora Therapeutics, Inc. | Chief Strategy Officer | Sell10b5-1 | 8,565 | $1.68 | $14,347.23 | -8.8% | -60.1% | +107.5% |